Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Vanguard Extended Market ETF (NY:VXF)

205.03 -2.05 (-0.99%)
Streaming Delayed Price Updated: 10:54 AM EDT, Aug 29, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Vanguard Extended Market ETF

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
BioXcel’s Sublingual Film Well-Tolerated In Bipolar, Schizophrenia Trial In At-Home Settings, Retail Says Buy Now Or Regret Later
Via Stocktwits
Soho House Nears $9-Share Go-Private Deal: Report
Via Stocktwits
Workhorse Group To Merge With Motive Electric Trucks: Retail’s Divided On The Combined Company Valuation
The combination will create a leading North American medium-duty electric truck original equipment manufacturer with a full range of Class 4-6 trucks valued at about $105 million, the companies said. 
Via Stocktwits
Topics Electric Vehicles
Verb Technology Stock Nearly Doubles On Monday, Retail Chatter Explodes A Whopping 1,100%: Here’s What’s Happening
Following the closing of a private placement, expected on or around August 7, the company will operate under the name TON Strategy Co. (TSC). 
Via Stocktwits
Imunon Doses First Patient With Experimental Cancer Drug In Late-Stage Trial: Retail Thinks Company Is Undervalued
Via Stocktwits
American Airlines Sparks Investor Debate After Q2 Beat, Cautious Outlook: Retail’s On Buying Spree
Via Stocktwits
Wendy's Announces 190 New Burger Chain Outlets In Italy and Armenia: Retail View Turns Bullish
Via Stocktwits
Stitch Fix Surges After William Blair Upgrade: Retail Still On The Fence
Via Stocktwits
Sonnet BioTherapeutics Stock Jumps 82% After Deal With Rorschach I: Retail Stays Exuberant
Via Stocktwits
Robinhood CEO Reportedly Defends OpenAI, SpaceX Tokens – Says Equity Is Not ‘Entirely Relevant’
Robinhood CEO Vlad Tenev defended offering stock tokens for OpenAI and SpaceX, saying equity status is secondary to giving retail investors access. 
Via Stocktwits
Topics ETFs Government
BofA Lowers Crocs Price Target, But Keeps 'Buy' Rating On Potential Upside In Foreign Market
Crocs' Q1 revenue and profit for the last quarter were above expectations, but the company withdrew its full-year 2025 outlook in May. 
Via Stocktwits
Topics World Trade
Robinhood Launches Tokens For EU Users To Trade US Stocks
Robinhood is expanding into Europe with tokenized stocks, crypto futures, and staking, aiming to merge traditional and digital assets through a mobile-first, blockchain-powered investment platform. 
Via Stocktwits
Topics Derivatives ETFs Lawsuit
Cineverse Stock Soars As Terrifier 3 Lifts Q4 Revenue: Retail Optimism Abounds
Cineverse Q4 revenue jumped 58% to $15.6 million, driven by Terrifier 3, with EPS and EBITDA exceeding expectations. 
Via Stocktwits
Topics Artificial Intelligence Government
Cyngn Stocks Soars On Nvidia Partnership, Robotics Showcase
The collaboration showed off Cyngn’s integration of the Nvidia Isaac robotics platform to advance its autonomous vehicle technology tailored for industrial environments. 
Via Stocktwits
Topics Artificial Intelligence Earnings
Sonim Technologies Stock Surges On AI Merger Plans With HPC Firm: Retail Turns Optimistic
Shareholders of the AI infrastructure company would control a majority interest in the combined organization, while Sonim investors would retain equity worth approximately $17.5 million. 
Via Stocktwits
Topics Artificial Intelligence
Nektar Therapeutics Announces Positive Data From Eczema Drug In Mid-stage Trial: Stock More Than Doubles But Retail Sees It Rising Further
Nektar Therapeutics said its mid-stage trial showed that patients who received Rezpegaldesleukin demonstrated improvement in eczema area and severity score compared to placebo at week 16. 
Via Stocktwits
Topics Economy Government
Cidara Therapeutics’ Market Cap Doubles After Investigational Drug Shows Positive Results In Preventing Influenza In Mid-stage Trial
Single doses of 450mg, 300mg, and 150mg of CD388 conferred 76%, 61%, and 58% protection, respectively, from symptomatic influenza over 24 weeks compared to placebo, the company said. 
Via Stocktwits
SeaStar Medical Stock Tanks At Discounted Pricing Of Public Offering, Retail Believes Company Is Inching Closer To Bankruptcy
The public offer price of $0.65 represents a 33% discount on the stock’s closing price on Wednesday. 
Via Stocktwits
Topics Bankruptcy
NextCure Inks $745M Deal With Simcere For Cancer Drug: Retail’s More Optimistic Despite Stock’s 27% Decline
The newly announced partnership aims to develop SIM0505, a novel antibody-drug conjugate developed by Simcere Zaiming for the treatment of solid tumors. 
Via Stocktwits
Sonim Technologies Stock Doubles After Company Confirms DOOGEE's Acquisition Proposal, Retail Goes All In
Sonim’s Special Committee, tasked with overseeing strategic alternatives, acknowledged the proposal but noted that it lacks the information needed to properly assess the offer. 
Via Stocktwits
Curiosity’s New Global Content, AI Licensing Deals Fail To Lift Retail Mood
Curiosity expands global reach through new international licensing deals across broadcasters and platforms, while tapping into AI training markets with its vast library of factual video and audio... 
Via Stocktwits
Topics Artificial Intelligence
ReShape Lifesciences Stock Soars On Distribution Agreement With Recon Supply, Draws Retail Applause
Under the distribution agreement, Recon Supply will distribute ReShape’s portfolio across the Veterans Administration and Department of Defense healthcare systems. 
Via Stocktwits
Retail Goes Gaga Over Inuvo Shares On Upbeat Q2 Outlook, Reverse Stock Split Plans
Inuvo expects at least 25% revenue growth in the second quarter and completed a 1-for-10 reverse stock split to boost stock liquidity and attract more institutional investors. 
Via Stocktwits
Topics Artificial Intelligence
Tonix Pharma Stock Plunges 20% Pre-market On Share Sale Announcement, But Retail’s Not Pessimistic
The proceeds from the purchase agreement are expected to be used for working capital and general corporate purposes. 
Via Stocktwits
Intelligent Bio Rises On Partnership With Smartox To Expand US Market Presence: Retail Hopes The Stock To Hit $2.6
Intelligent Bio is actively pursuing FDA clearance for its opiate test system for codeine, utilizing its fingerprint sweat-based testing technology. 
Via Stocktwits
Stitch Fix's Forecast Bump After Strong Q3 Print Lifts Shares And Retail Sentiment
The company reported progress on its turnaround strategy. 
Via Stocktwits
Ernexa Stock Drops On 1-For-15 Reverse Stock Split To Regain Nasdaq Compliance: Retail Sentiment Improves But Stays Bearish
As of Tuesday, the company had 110.4 million shares of common stock issued and outstanding, which it anticipates will result in approximately 7.4 million shares on a split-adjusted basis. 
Via Stocktwits
ReShape Lifesciences Stock Slumps As Company Prices Public Offering At Significant Discount: Retail Holds On To Optimism
The offer price of $2.50 represents a 40% discount to the stock’s closing price of $4.18 on Friday. 
Via Stocktwits
Robinhood Stock Declines After Failing To Make It To S&P 500 Index During Quarterly Rebalancing
Investor hopes were high after Bank of America said last week that HOOD stock is a prime candidate to join the S&P 500. 
Via Stocktwits
Topics Stocks
Recreational Vehicle-Maker Winnebago Slumps On Weak Preliminary Q3 Report As Tariffs, Weak Demand Pressures Bite
The firm is considering reducing shipments, implementing cost-cutting measures, and workforce reductions. 
Via Stocktwits
Topics World Trade
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.